SWTX
Springworks Therapeutics Inc
$42.89
Earnings Summary
Revenue | $5.45Mn |
Net Profits | $-94.32Mn |
Net Profit Margins | -1731.63% |
Highlights
Springworks Therapeutics Inc’s revenue fell -6.07% since last year same period to $5.45Mn in the Q4 2023. On a quarterly growth basis, Springworks Therapeutics Inc has generated -2.49% fall in its revenue since last 3-months.
Springworks Therapeutics Inc’s net profit fell -34.93% since last year same period to $-94.32Mn in the Q4 2023. On a quarterly growth basis, Springworks Therapeutics Inc has generated -18.74% fall in its net profits since last 3-months.
Springworks Therapeutics Inc’s net profit margin fell -43.65% since last year same period to -1731.63% in the Q4 2023. On a quarterly growth basis, Springworks Therapeutics Inc has generated -21.77% fall in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Springworks Therapeutics Inc post its latest quarter earnings
EPS Estimate Current Quarter | -1.19 |
EPS Estimate Current Year | -1.19 |
Highlights
Springworks Therapeutics Inc’s earning per share (EPS) estimates for the current quarter stand at -1.19 - a 4.03% jump from last quarter’s estimates.
Springworks Therapeutics Inc’s earning per share (EPS) estimates for the current year stand at -1.19.
Key Ratios
Key ratios of the Springworks Therapeutics Inc post its Q4 2023 earnings
Earning Per Share (EPS) | -1.45 |
Highlights
Springworks Therapeutics Inc’s earning per share (EPS) fell -23.93% since last year same period to -1.45 in the Q4 2023. This indicates that the Springworks Therapeutics Inc has generated -23.93% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2023-11-02 | -1.33 | -1.27 | 4.51% |
2023-08-02 | -1.26 | -1.25 | 0.79% |
2023-05-03 | -1.25 | -1.18 | 5.6% |
2024-02-27 | -1.24 | -1.45 | -16.94% |
₹0 US Stocks a/c Opening Fee